Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Research

19-NEU-325-deep-gray-matter_650x450

Assessing Deep Gray Matter Atrophy as a Predictor of Clinical Disability in MS

Study finds strong association between brain/thalamic volume and T2 lesion volume

19-NEU-326-multiple-sclerosis-650×450

Highly Effective Therapies Used in Only a Minority of Relapsing MS Cases, Study Finds

Prescribing practices analyzed over 12+ years across 10 sites

19-NEU-324-SPRINT-MS-650×450

SPRINT-MS Subanalysis Shows Greater Effect for Ibudilast in Primary Vs. Secondary Progressive MS

Findings may be due to faster atrophy progression in primary progressive MS

19-NEU-446-stereotactic-laser-ablation-brain-tumor-650×450
April 19, 2019/Cancer

Trends in Stereotactic Laser Ablation for Brain Tumors: Mounting Experience and Enhanced Technology Are Boosting Outcomes

Insights from 240 cases over 8 years at Cleveland Clinic

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-NEU-217-opioids-650x450pxl
April 17, 2019/Neurosciences/Research

Prescribing Limits Drive Down Opioid Exposure After Spine Surgery Without Harming Outcomes

Cleveland Clinic study assesses effects of state-level reforms

19-NEU-272-Spine-Steinmetz-650×450
April 15, 2019/Neurosciences/Research

Is Intraoperative Multimodal Monitoring Indicated for PSOs of the Lumbar Spine?

Retrospective analysis finds no evidence of benefit, but more study needed

19-NEU-306-Recinos-650×450
April 12, 2019/Cancer

Good QOL Outcomes Achieved After Extended Bifrontal Resection for Giant Meningiomas

Pilot study supports routine neuropsychological testing before and after the surgery

19-NEU-258-Woman-MS-Wheelchair-640241694
March 27, 2019/Neurosciences/Research

A Window into Patients’ Perceptions of the Risks of Multiple Sclerosis Therapies

Large survey shows wide variability in risk tolerance, high levels of risk aversion

19-NEU-230-ghoshEpilepsia-hero-650×450

Insights on Glucocorticoid Receptors’ Role in Drug-Resistant Epilepsy

In vitro model of blood-brain barrier points to potential therapeutic target

Stroke concept
February 6, 2019/Neurosciences/Research

Ischemic Stroke Risk Factors Are on the Rise in Native Americans

Study finds modifiable factors — hypertension and smoking — moving in the wrong direction

BackPage 9 of 14Next

Advertisement

Ad